The IκB kinase inhibitor PS-1145 was shown to block TNF-α-induced NF-κB activation in multiple myeloma cells through inhibition of IκBα phosphorylation and degradation (42). The gene discussed is NFKBIA; the disease is plasma cell myeloma.